Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
22 March 2018
General meetings

Auditor’s report on resolutions 15-21 and 26 – 2018 General Meeting Open in new window

22 March 2018
General meetings

2017 Annual Report Open in new window

22 March 2018
General meetings

Auditor’s report on resolution 22 – 2018 General Meeting Open in new window

22 March 2018
General meetings

Auditor’s report on resolution 23 – 2018 General Meeting Open in new window

22 March 2018
General meetings

Auditor’s report on resolution 24 – 2018 General Meeting Open in new window

22 March 2018
General meetings

Auditor’s report on resolution 25 – 2018 General Meeting Open in new window

22 March 2018
General meetings

Third party’s report on the 2017 Company’s CSR report Open in new window

28 July 2017
Financial statements and reports

2017 Half-Year Financial Report Open in new window

06 July 2017
Regulated information

Half-Year Report on the Liquidity Contract Open in new window

23 June 2017
Regulated information

Note d’opération visa 17-297 Open in new window

  • View previous 9 articles
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page